Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Biomarin Pharmaceutical

55.55
-0.0400-0.07%
Post-market: 55.550.00000.00%16:28 EDT
Volume:939.90K
Turnover:52.37M
Market Cap:10.67B
PE:30.86
High:56.06
Open:55.36
Low:55.20
Close:55.59
52wk High:73.18
52wk Low:50.76
Shares:192.11M
Float Shares:178.10M
Volume Ratio:0.40
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.80
EPS(LYR):1.80
ROE:5.94%
ROA:5.58%
PB:1.75
PE(LYR):30.86

Loading ...

OverviewCompanyNewsFilings

Will Growing Free Cash Flow Margins Redefine BioMarin Pharmaceutical’s (BMRN) Rare Disease Leadership?

Simply Wall St.
·
Oct 18, 2025

BioMarin Pharmaceutical (BMRN) Receives a Buy from Cantor Fitzgerald

TIPRANKS
·
Oct 15, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: CVS Health (CVS) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Oct 10, 2025

J.P. Morgan Keeps Their Buy Rating on BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Oct 10, 2025

Biomarin Pharmaceutical Inc: Expects Q3 Will Include Acquired Ipr&D Charges of Approximately $221 Mln on a Pre-Tax Basis Due to Inozyme Pharma Deal

THOMSON REUTERS
·
Oct 08, 2025

Biomarin Pharmaceutical Inc - for Q3, Co Expects Charge of About $1.10 to Both Gaap and Non-Gaap EPS Due to Inozyme Pharma Deal

THOMSON REUTERS
·
Oct 08, 2025

BioMarin updates financial impact of Inozyme Pharma acquisition with estimated 221 million charge in Q3 2025

Reuters
·
Oct 08, 2025

Should Positive Phase 3 PALYNZIQ Results Prompt Action From BioMarin (BMRN) Investors?

Simply Wall St.
·
Oct 05, 2025

Analyst Rate

Buy
Buy
80.00%
Hold
20.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Feb 23, 2026 Post Market
Financial Report Announcement
Oct 27, 2025 Post Market
Financial Report Announcement
Aug 04, 2025 Post Market
Financial Report Announcement
May 01, 2025 Post Market
Financial Report Announcement
Feb 19, 2025 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

30.86
Current
157.48
Sector Average
33.57%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
30.86
Maximum
1,055.05
+1 STD
410.22
Minimum
-246.96
-1 STD
-95.27
Average
157.48

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.